Stem Cells Australia was established in 2011 with the support of the Australian Government through the Australian Research Council's Special Research Initiatives scheme, with the objective of discovering how to regulate stem cells. Stem Cells Australia is now capitalising on its initial research findings to harness the potential of stem cells for diagnostic, therapeutic and biotechnological purposes. The consortium links over 300 experts in bioengineering, nanotechnology, stem cell biology, advanced molecular analysis and clinical research across 14 Australian universities and research institutes. The University of Melbourne is the administering organisation for the initiative.
| Website | http://www.stemcellsaustralia.edu.au |
| Revenue | $19 million |
| Employees | View employees |
| Phone | +61 3 9035 8639 |
| Industry | Business Services General, Business Services |
| Competitors | Mesoblast Limited, Cynata Therapeutics, Cell Therapies Pty Ltd, Cellerant Therapeutics, Athersys, HemoShear Therapeutics, bluebird bio, Organogenesis, Catalent Pharma Solutions, Tissue Regenix Group +33 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies |
Looking for a particular Stem Cells Australia employee's phone or email?
Stem Cells Australia Questions
The Stem Cells Australia annual revenue was $19 million in 2026.
Stem Cells Australia is based in Melbourne, Victoria.
The NAICS codes for Stem Cells Australia are [5417, 541, 54171, 541713, 54].
The SIC codes for Stem Cells Australia are [87, 873].
